Results 151 to 160 of about 349,819 (308)

Incidence and risk factors for postpartum infections: A Norwegian cohort study, 2012–2020

Acta Obstetricia et Gynecologica Scandinavica, EarlyView.
Nationwide registry data from 516 874 deliveries in Norway (2012–2020) show that postpartum infections are common and that endometritis/puerperal sepsis is increasing. Delivery‐related factors, especially emergency cesarean section, postpartum hemorrhage, and chorioamnionitis, show the strongest associations.
Kjerstine Røe, Ingvil Krarup Sørbye, Cecilie Fredvik Torkildsen, Anders Engeland, Hilde Marie Engjom, Roy Miodini Nilsen, Kari Klungsøyr   +6 more
wiley   +1 more source

Ebola hemorrhagic fever [French]

Ebola hemorrhagic fever [French]Ebola hemorrhagic fever [fran\ue7ais]La fi\ue8vre h\ue9morragique Ebola (Ebola FH) est l'une des nombreuses fi\ue8vres h\ue9morragiques virales.

core   +1 more source

CRIMEAN-CONGO HEMORRHAGIC FEVER: AN EMERGING DILEMMA IN PAKISTAN

Gomal Journal of Medical Sciences, 2017
.
Ahmad Jan Khan, Javaid Hussain
doaj  

Minimal residual disease–guided ibrutinib and venetoclax in patients with chronic lymphocytic leukaemia and complex karyotype

British Journal of Haematology, EarlyView.
Minimal residual disease (MRD)–guided ibrutinib and venetoclax (IVen) achieved durable remissions and high undetectable MRD (uMRD) rates in patients with high‐risk chronic lymphocytic leukaemia (CLL). Compared with historical ibrutinib monotherapy, IVen was associated with improved progression‐free and overall survival despite presence of complex ...
Maria Kislova, Elena Dmitrieva, Elena Naumova, Margarita Pochtar, Svetlana Lugovskaya, Yury Kobzev, Alla Loban, Maria Gladysheva, Tatiana Obukhova, Bella Biderman, Andrey Sudarikov, Egor Volchkov, Maria Ivanova, Vadim Ptushkin, Andrea Visentin, Eugene Nikitin   +15 more
wiley   +1 more source

Crimean-congo hemorrhagic fever virus in ticks from imported livestock, Egypt. [PDF]

, 2012
Alia Zayed, Chisholm, Katherine, Katherine Chisholm, Fahmy, Nermeen T, Samaha, Hamed Abdel Tawab, Hamed Abdel Tawab Samaha, Jeffrey T. Villinski, Erica Dueger, Nermeen T. Fahmy, Zayed, Alia, Mahmoud Abdel-Dayem, Dueger, Erica, Villinski, Jeffrey T, Abdel-Dayem, Mahmoud   +13 more
core   +1 more source

SAKK 35/14 randomized trial of rituximab with or without ibrutinib for patients with untreated follicular lymphoma

British Journal of Haematology, EarlyView.
Summary The randomized phase II SAKK 35/14 trial, conducted by the Swiss Group for Clinical Cancer Research (SAKK) and the Nordic Lymphoma Group (NLG), compared efficacy and safety of rituximab (375 mg/m2 intravenously for 4 weeks followed by maintenance every 2 months for 24 months) plus placebo (arm A) versus the same schedule of rituximab plus ...
Maria Cristina Pirosa, Marianne Brodtkorb, Sämi Schär, Björn E. Wahlin, Micaela Hernberg, Michael Pedersen, Anastasios Stathis, Thilo Zander, Urban Novak, Thorsten Zenz, Natalie Fischer, Fatime Krasniqi, Felicitas Hitz, Ann‐Sofie Johansson, David Löfgren, Peter Albert Meyer, Anne Turid Bjørnevik, Giulio Sartori, Stefanie Hayoz, Andrea Fuhrer, Luzia Steiner, Francesco Bertoni, Luca Ceriani, Stefan Dirnhofer, Emanuele Zucca, Bjørn Østenstad   +25 more
wiley   +1 more source

Reduced Circulating Angiopoietin-Like Protein Levels in Crimean-Congo Hemorrhagic Fever. [PDF]

APMIS
Yeşildağ S, Büyüktuna SA, Öksüz C, Doğan HO.   +3 more
europepmc   +1 more source

Phase II Study of Cisplatin/Gemcitabine Plus Necitumumab for Squamous NSCLC After ICI‐Platinum Therapy (WJOG14120L)

Cancer Science, EarlyView.
WJOG14120L NESSIE evaluated cisplatin, gemcitabine, and necitumumab (CGN) as second‐line therapy after ICI‐based treatment in 46 patients with advanced squamous NSCLC. ORR was 26.1%, DCR 87.0%, and median PFS 4.4 months. Although the predefined ORR threshold was not met, CGN showed modest antitumor activity with manageable toxicity.
Hiroshige Yoshioka, Keita Mori, Nobuhisa Ishikawa, Hiroaki Kanemura, Koichi Azuma, Yukihiro Toi, Hiroshi Handa, Yosuke Tamura, Hiroaki Akamatsu, Haruko Daga, Masafumi Yamaguchi, Teppei Yamaguchi, Yuki Sato, Nobuyuki Yamamoto, Kazuhiko Nakagawa, Takayasu Kurata   +15 more
wiley   +1 more source

Crimean-Congo Hemorrhagic Fever Disease Awareness Scale: Scale Development, Validity, and Reliability Study. [PDF]

JMIR Public Health Surveill
Yilmazel G, Çalmaz A, Keleş E.
europepmc   +1 more source

Fibrillar‐Type Dermatitis Herpetiformis: An Underrecognized Variant That Is Rarely Associated With Celiac Disease and Lacking Epidermal Transglutaminase Deposition: A Report of Two Cases

Journal of Cutaneous Pathology, EarlyView.
ABSTRACT Dermatitis herpetiformis (DH) is a rare, intensely pruritic cutaneous manifestation of celiac disease (CD), typically presenting with excoriated papulovesicular lesions on extensor surfaces. DH is associated with IgA autoantibodies against epidermal transglutaminase (eTG), which form granular immune deposits in the papillary dermis and induce ...
Jeffrey Damman, Elodie Mendels, Sven van der Woude, Sharon Veenbergen, Gilles F. H. Diercks, Martijn B. van Doorn   +5 more
wiley   +1 more source